Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4862838
Max Phase: Preclinical
Molecular Formula: C24H21F4N3O2
Molecular Weight: 459.44
Molecule Type: Unknown
Associated Items:
ID: ALA4862838
Max Phase: Preclinical
Molecular Formula: C24H21F4N3O2
Molecular Weight: 459.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NC[C@@H](F)CO)c1cccc2c1CCN2c1cc(Cc2cc(F)c(F)c(F)c2)ccn1
Standard InChI: InChI=1S/C24H21F4N3O2/c25-16(13-32)12-30-24(33)18-2-1-3-21-17(18)5-7-31(21)22-11-14(4-6-29-22)8-15-9-19(26)23(28)20(27)10-15/h1-4,6,9-11,16,32H,5,7-8,12-13H2,(H,30,33)/t16-/m1/s1
Standard InChI Key: WJYZKQVRVCLZNH-MRXNPFEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 459.44 | Molecular Weight (Monoisotopic): 459.1570 | AlogP: 3.84 | #Rotatable Bonds: 7 |
Polar Surface Area: 65.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.56 | CX LogP: 4.22 | CX LogD: 4.21 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.42 | Np Likeness Score: -1.01 |
1. (2020) 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto, |
Source(1):